Vifor Pharma
Vifor Pharma is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases.
Business Model:
Revenue: $1.9B
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Vifor Pharma Information
Vifor Pharma was acquired by
CSL.
The acquisition happend on 2021-12-14.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Flughofstrasse 61
City: Glattbrugg
State: other
Zip: CH-8152
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
1,608,335Website Global Rank
12,465Website Monthly Traffic
Twitter Followers
Description
Vifor Pharma is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases.
Contact Phone:
Contact Email:
Vifor Pharma went public on 4/17/2017 on the SIX Swiss Exchange
Listed Exchange:
SIX Swiss Exchange
IPO Date:
4/17/2017
Ticker Symbol:
VIFN
Amount Raised:
$2B
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2021 | Angion Biomedica | Post-IPO Equity | 25M |
| 2/2021 | Angion | Post-IPO Equity | 0 |
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
